Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Sealbond Ltd — Virios Therapeutics, Inc. insider · InsiderLens

Home / Insiders / Sealbond Ltd

Sealbond Ltd

10% owner at Virios Therapeutics, Inc. · on record since Oct 17, 2024
Director at Virios Therapeutics, Inc. · on record since Nov 25, 2025
See Remarks at Virios Therapeutics, Inc. · on record since Nov 25, 2025

Insider trading activity of Sealbond Ltd

No transactions on record for Sealbond Ltd.

Track record of Sealbond Ltd

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Sealbond Ltd

Co-insiders of Sealbond Ltd

Burch Richard AlanVirios Therapeutics, Inc.
CK Life Sciences Intl (Holdings) IncVirios Therapeutics, Inc.
Conjoint Inc.Virios Therapeutics, Inc.
De La Rosa AbelVirios Therapeutics, Inc.
Duncan Gregory ScottVirios Therapeutics, Inc.
Gendreau Roger MichaelVirios Therapeutics, Inc.
Grosswald RalphVirios Therapeutics, Inc.
Keefer David RVirios Therapeutics, Inc.
Pridgen WilliamVirios Therapeutics, Inc.
Thomas John CVirios Therapeutics, Inc.
Toh Kean Meng MelvinVirios Therapeutics, Inc.
Walsh AngelaVirios Therapeutics, Inc.
Whitley Richard JamesVirios Therapeutics, Inc.
Yu Ying Choi Alan AbelVirios Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

No transactions on record. Reset filters